Autres langues AstraZeneca PLC

Actions

AZN

GB0009895292

Produits pharmaceutiques

Marché Fermé - London S.E. 17:35:20 04/09/2026			Varia. 5j.	Varia. 1 janv.
12 006,00 ^GBX	-1,15%		+0,30%	-12,94%

02:09	AstraZeneca obtient le feu vert aux États-Unis pour la combinaison Etcamah contre le cancer du sein	AN
06/09	États-Unis : autorisation de la combinaison Etcamah d'AstraZeneca pour le traitement du cancer du sein avancé	MT

Autres langues

02:09	AstraZeneca wins US nod for Etcamah breast cancer combo
06/09	AstraZeneca's Etcamah Combination Authorized for Advanced Breast Cancer Treatment in US
05/09	Astrazeneca Receives Approval for Etcamah in Combination with A Cdk4/6 Inhibitor for 1St-Line Advanced Hr-Positive Breast Cancer in the US
05/09	AstraZeneca?s ETCAMAH (camizestrant) in combination with a cyclin-dependent kinase 4/6 inhibitor (abemaciclib, palbociclib or ribociclib) has been approved in the US
05/09	ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer
05/09	AstraZeneca Wins FDA Accelerated Approval for Breast Cancer Drug Etcamah
04/09	FDA Approves AstraZeneca Treatment for Advanced Breast Cancer -- Update
04/09	AstraZeneca : Etcamah in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer
04/09	AstraZeneca Gets FDA Approval for Breast Cancer Treatment
04/09	AstraZeneca : Share price weakness of late, should be capitalised on
03/09	UK stocks rise as bond rally lifts risk sentiment
03/09	AstraZeneca Kept at Buy as Berenberg Notes Upcoming COPD Data Readout
03/09	UK stocks recover as bond rally lifts risk sentiment
03/09	Morning Meeting: Comienzo sombrío de la temporada bursátil de otoño
02/09	Owkin signs AI drug discovery deal with Boehringer for cancer, immunology
02/09	AstraZeneca finalizes the acquisition of global rights to Zegfrovy
01/09	London Shares Fall Amid Shop Price Inflation, Renewed US-Iran Tensions
01/09	European Stocks Close Mostly Lower in Tuesday Trading; Euro Area Inflation Surges in August
01/09	Global markets live: Amazon, Tesla, Nvidia, Apple, Eli Lilly…
01/09	Astrazeneca plc and Dizal Pharmaceutical Co., Ltd Complete Global License Agreement for Oral Egfr Inhibitor Zegfrovy for Lung Cancer
01/09	Hutchmed "thrilled" by positive phase 3 trial results
01/09	Global pharma companies that have publicly announced Trump drug pricing agreements
01/09	AstraZeneca completes global license agreement for oral EGFR inhibitor ZEGFROVY® (sunvozertinib) for lung cancer
01/09	AstraZeneca unveils Zegfrovy deal, lung trial win and Enhertu approval
01/09	WINNERS & LOSERS: Oil majors rise, miners slide on lower metals prices